Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32166
Abstract: To the authors' knowledge, the indications for radioactive iodine (RAI) therapy in patients with differentiated thyroid carcinoma (DTC) are unclear; treatment decisions are based on physician judgment. The objective of the current study was to…
read more here.
Keywords:
patients differentiated;
radioactive iodine;
differentiated thyroid;
thyroid carcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Endocrine"
DOI: 10.1007/s12020-017-1345-y
Abstract: In 2015, the American Thyroid Association (ATA) published evidence-based guidelines for the management and follow-up of patients with differentiated thyroid cancer (DTC) [1]. While many of the updated recommendations can be easily integrated into clinical…
read more here.
Keywords:
management;
patients differentiated;
risk;
thyroid cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001605
Abstract: Objective The aim of this study was to evaluate the effect of vitamin E and supragingival scaling with vitamin C on the salivary glands of patients with differentiated thyroid carcinoma after 131I treatment. Methods A…
read more here.
Keywords:
patients differentiated;
vitamin;
gland;
group ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001639
Abstract: Aim To evaluate the prognostic value of postoperative Tc-99m pertechnetate scanning in patients with differentiated thyroid cancer (DTC). Method Patients with pathologically proven low or intermediate-risk DTC were enrolled in this study. Postoperative Tc-99m pertechnetate…
read more here.
Keywords:
patients differentiated;
99m pertechnetate;
pertechnetate;
thyroid scan ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Annals of Clinical Biochemistry"
DOI: 10.1177/00045632231154727
Abstract: Background Measurement of antithyroglobulin antibodies (TgAb) is important in patients with differentiated thyroid carcinoma (DTC) with total thyroidectomy. These patients are monitored based on serum thyroglobulin (Tg) levels. TgAb is known to interfere with the…
read more here.
Keywords:
thyroid carcinoma;
methodology;
patients differentiated;
differentiated thyroid ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "European thyroid journal"
DOI: 10.1530/etj-22-0219
Abstract: BACKGROUND Purpose To determine whether thyroid stimulating hormone level ≥30 mU/l is necessary for radioiodine (131I) remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC), as well as its influencing factors and predictors. METHODS…
read more here.
Keywords:
patients differentiated;
differentiated thyroid;
rra;
remnant ablation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2019.00146
Abstract: Background: In patients with differentiated thyroid cancer (DTC) and raising serum thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an empiric 131I therapy may be considered. However, outcome data after empiric therapy…
read more here.
Keywords:
patients differentiated;
differentiated thyroid;
thyroid cancer;
serum thyroglobulin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14081899
Abstract: Simple Summary A higher tumor burden in patients with differentiated thyroid cancer undergoing radioactive iodine (131I) therapy may release into the bloodstream large amounts of 131I with a long residence time. We hypothesized that after…
read more here.
Keywords:
patients differentiated;
differentiated thyroid;
lymphocyte;
thyroid cancer ... See more keywords